Breaking News

ProBio Opens New Facility in Hopewell, NJ

This plasmid DNA and viral vector manufacturing facility will serve as the hub for North American operations.

Author Image

By: Charlie Sternberg

Associate Editor

ProBio Inc., a New Jersey-based contract development and manufacturing organization (CDMO), has expanded its plasmid DNA and viral vector manufacturing capabilities with the opening of a new facility in Hopewell, New Jersey.   This facility will serve as the hub for North American operations, significantly enhancing ProBio’s capability to support the manufacturing of cell and gene therapies in North America.   The Hopewell facility spans approximately 128,000 square feet; it encompasse...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters